Defence molecules in intestinal innate immunity against bacterial infections

Current Opinion in Gastroenterology

Volumn 21, Issue 2, 2005, Pages 147-151

  Eckmann, Lars ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Cathelicidins; Defensins; Intestine; Mucosal immunology

Indexed keywords

ALPHA DEFENSIN; ANGIOGENIN; CATHELICIDIN; CATHELIN; EOSINOPHIL CATIONIC PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HISTONE H2B; INTERLEUKIN 1BETA; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE A2; PURINE P2X7 RECEPTOR; RIBOSOME PROTEIN; SERINE PROTEINASE; TOLL LIKE RECEPTOR;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; CELL DIFFERENTIATION; COLON MUCOSA; DENDRITIC CELL; DRUG ACTIVITY; DRUG INHIBITION; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; NEUTROPHIL; NONHUMAN; PANETH CELL; PROTEIN EXPRESSION; REVIEW; STOMACH EPITHELIUM;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; DEFENSINS; HUMANS; IMMUNITY, NATURAL; INTESTINE, SMALL;

EID: 14644414161     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mog.0000153311.97832.8c     Document Type: Review

References (37)

1. Inohara N, Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 2003; 3:371-382.
2. Girardin SE, Philpott DJ. Mini-review: the role of peptidoglycan recognition in innate immunity. Eur J Immunol 2004; 34:1777-1782.
3. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4:499-511.
4. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5:987-995.
5. Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol 2004; 5:975-979.
6. Abreu MT, Arditi M. Innate immunity and toll-like receptors: clinical implications of basic science research. J Pediatr 2004; 144:421-429.
7. Patil A, Hughes AL, Zhang G. Rapid evolution and diversification of mammalian α-defensins as revealed by comparative analysis of rodent and primate genes. Physiol Genomics 2004; 20:1-11. This paper is the first to present a complete comparative genome analysis of α-defensin genes in rodents and humans.
8. Hornef MW, Putsep K, Karlsson J, et al. Increased diversity of intestinal antimicrobial peptides by covalent dimer formation. Nat Immunol 2004; 5:836-843. This important study shows for the first time that different antimicrobial peptides can form covalently linked heterodimers with altered and enhanced antimicrobial activity, suggesting that the structural and functional diversity of mammalian antimicrobial peptides is even larger than indicated by genome analysis.
9. Salzman NH, Chou MM, de Jong H, et al. Enteric salmonella infection inhibits Paneth cell antimicrobial peptide expression. Infect Immun 2003; 71:1109-1115. The paper provides evidence for the interesting new concept that bacterial pathogens can attenuate the expression of antimicrobial defence molecules as a potential virulence strategy.
10. Chavakis T, Cines DB, Rhee JS, et al. Regulation of neovascularization by human neutrophil peptides (α-defensins): a link between inflammation and angiogenesis. FASEB J 2004; 18:1306-1308.
11. Lin PW, Simon PO Jr, Gewirtz AT, et al. Paneth cell cryptdins act in vitro as apical paracrine regulators of the innate inflammatory response. J Biol Chem 2004; 279:19902-19907.
12. Wilson CL, Ouellette AJ, Satchell DP, et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999; 286:113-117.
13. Maxwell Al, Morrison GM, Dorin JR. Rapid sequence divergence in mammalian beta-defensins by adaptive evolution. Mol Immunol 2003; 40:413-421.
14. O'Neil DA, Porter EM, Elewaut D, et al. Expression and regulation of the human β-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999; 163:6718-6724.
15. Zaalouk TK, Bajaj-Elliott M, George JT, McDonald V. Differential regulation of beta-defensin gene expression during Cryptosporidium parvum infection. Infect Immun 2004; 72:2772-2779. The data in this paper, along with [9], indicate the enteric pathogens may down-regulate antimicrobial peptide expression to bypass innate host defences.
16. Wehkamp J, Harder J, Weichenthal M, et al. Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2003; 9:215-223.
17. Fahlgren A, Hammarstrom S, Danielsson A, Hammarstrom ML. beta-Defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis. Clin Exp Immunol 2004; 137:379-385.
18. Moser C, Weiner DJ, Lysenko E, et al. β-Defensin 1 contributes to pulmonary innate immunity in mice. Infect Immun 2002; 70:3068-3072.
19. Morrison G, Kilanowski F, Davidson D, Dorin J. Characterization of the mouse β defensin 1, Defb1, mutant mouse model. Infect Immun 2002; 70:3053-3060.
20. Hase K, Eckmann L, Leopard JD, et al. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 2002; 70:953-963.
21. Hase K, Murakami M, Iimura M, et al. Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology 2003; 125:1613-1625.
22. Sorensen OE, Follin P, Johnsen AH, et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001; 97:3951-3959.
23. Murakami M, Lopez-Garcia B, Braff M, et al. Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J Immunol 2004; 172:3070-3077. This interesting work demonstrates that human cathelicidin can be processed posttranslationally into smaller peptides with altered and enhanced microbial activity and specificity.
24. Sorensen OE, Gram L, Johnsen AH, et al. Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin: a novel mechanism of generating antimicrobial peptides in vagina. J Biol Chem 2003; 278:28540-28546. This study, along with [23], provides important evidence that posttranslational processing of the preproprotein of human cathelicidin can give rise to different antimicrobial peptides with different activities.
25. Nizet V, Ohtake T, Lauth X, et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001; 414:454-457.
26. Rosenberger CM, Gallo RL, Finlay BB. Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc Natl Acad Sci USA 2004; 101:2422-2427. This very important work provides the first evidence that cathelicidin is expressed in macrophages as part of their antimicrobial arsenal.
27. Koczulla R, von Degenfeld G, Kupatt C, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003; 111:1665-1672.
28. Davidson DJ, Currie AJ, Reid GS, et al. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol 2004; 172:1146-1156. The study shows that human cathelicidin can modulate dendritic cell differentiation, thus providing evidence for a link between innate and acquired immunity.
29. Tjabringa GS, Aarbiou J, Ninaber DK, et al. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol 2003; 171:6690-6696.
30. Elssner A, Duncan M, Gavrilin M, Wewers MD. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol 2004; 172:4987-4994.
31. Tollin M, Bergman P, Svenberg T, et al. Antimicrobial peptides in the first line defence of human colon mucosa. Peptides 2003; 24:523-530.
32. Howell SJ, Wilk D, Yadav SP, Bevins CL. Antimicrobial polypeptides of the human colonic epithelium. Peptides 2003; 24:1763-1770.
33. Hiemstra PS, van den Barselaar MT, Roest M, et al. Ubiquicidin, a novel murine microbicidal protein present in the cytosolic fraction of macrophages. J Leukoc Biol 1999; 66:423-428.
34. Birkemo GA, Luders T, Andersen O, et al. Hipposin, a histone-derived antimicrobial peptide in Atlantic halibut (Hippoglossus hippoglossus L.). Biochim Biophys Acta 2003; 1646:207-215.
35. Rose FR, Bailey K, Keyte JW, et al. Potential role of epithelial cell-derived histone H1 proteins in innate antimicrobial defense in the human gastrointestinal tract. Infect Immun 1998; 66:3255-3263.
36. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003; 4:269-273. The study is the first to demonstrate that members of the angiogenin family of host defence-related ribonucleases are expressed in the intestinal tract and may function as antimicrobial peptides against enteric bacteria.
37. Ganz T. Angiogenin: an antimicrobial ribonuclease. Nat Immunol 2003; 4:213-214.